Correlation Between BC Bud and Cannara Biotech
Can any of the company-specific risk be diversified away by investing in both BC Bud and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BC Bud and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The BC Bud and Cannara Biotech, you can compare the effects of market volatilities on BC Bud and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BC Bud with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of BC Bud and Cannara Biotech.
Diversification Opportunities for BC Bud and Cannara Biotech
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between BCBCF and Cannara is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding The BC Bud and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and BC Bud is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The BC Bud are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of BC Bud i.e., BC Bud and Cannara Biotech go up and down completely randomly.
Pair Corralation between BC Bud and Cannara Biotech
Assuming the 90 days horizon The BC Bud is expected to generate 5.71 times more return on investment than Cannara Biotech. However, BC Bud is 5.71 times more volatile than Cannara Biotech. It trades about 0.05 of its potential returns per unit of risk. Cannara Biotech is currently generating about 0.03 per unit of risk. If you would invest 8.75 in The BC Bud on August 29, 2024 and sell it today you would lose (4.20) from holding The BC Bud or give up 48.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
The BC Bud vs. Cannara Biotech
Performance |
| Timeline |
| BC Bud |
| Cannara Biotech |
BC Bud and Cannara Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BC Bud and Cannara Biotech
The main advantage of trading using opposite BC Bud and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BC Bud position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.| BC Bud vs. Amexdrug | BC Bud vs. Crescita Therapeutics | BC Bud vs. Antisense Therapeutics Limited | BC Bud vs. Aion Therapeutic |
| Cannara Biotech vs. Benchmark Botanics | Cannara Biotech vs. Speakeasy Cannabis Club | Cannara Biotech vs. City View Green | Cannara Biotech vs. BC Craft Supply |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |